Repligen reports no adverse effects in phase 1 clinical study so far dne October 30, 2011 Quinazoline Repligen RG3039 +1 spinal muscular atrophy cure spinal muscular atrophy research Quinazoline Repligen RG3039 spinal muscular atrophy cure spinal muscular atrophy research
The Current Status of Spinal Muscular Atrophy Therapeutics dne October 16, 2011 ISIS SMNrx Olesoxime Quinazoline +4 spinal muscular atrophy spinal muscular atrophy cure spinal muscular atrophy research stem cell Trophos ISIS SMNrx Olesoxime Quinazoline spinal muscular atrophy spinal muscular atrophy cure spinal muscular atrophy research stem cell Trophos
ISIS SMNrx Improves Lifespan and Motor Function in SMA Mice dne October 09, 2011 ISIS SMNrx spinal muscular atrophy cure + spinal muscular atrophy research ISIS SMNrx spinal muscular atrophy cure spinal muscular atrophy research